본문 바로가기
KERD
논문KCI 등재

후두 편평세포병변에서 CD44v3의 발현 의의

The Significance of CD44v3 Expression in Squamous Cell Lesions of the Larynx

최성준|조성일|이준한|임성철|임태승|도남용
대한이비인후과학회 (Korean Society of Otorhinolaryngology-Head and Neck Surgery)|2005.03|대한이비인후과학회지 두경부외과학 (Korean Journal of Otorhinolaryngology-Head and Neck Surgery)|제48권 제3호|pp. 357-361

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

AntigenCD4·후두·편평세포병변.CD44· Larynxcarcinoma· Squamous cell.
주제분류이비인후과학

초록

Abstract

Background and Objectives：It is known that a part of laryngeal premalignant lesions progresses to an invasive carcinoma. Despite many previous reports, conventional histology is not sufficient to predict such tumor progression. Herein, the authors investigated the role of CD44v3 as a biomarker in predicting the progression of laryngeal premalignant lesion to an inavasive cancer. Subjects and Method：Paraffin-embedded tissue specimens from 40 patients were diagnosed accordingly as laryngeal invasive squamous cell carcinoma (n=10), Carcinoma in situ (n=10), dysplasia (n=10), and hyperkeratosis (n=10) between 1993 and 2002. They were immunohistochemically stained for CD44v3 protein. Results：In invasive squamous cell carcinoma, the expression of CD44v3 was diffused and gave a strong positive stain, and in carcinoma in situ, it was diffused and gave 3+-2+ stain. However, in dysplasia and hyperkeratosis, the proportion of CD44v3 expression was decreased by 2+-1+, and 1+ -0, respectively. Conclusion：These results suggest that the expression of CD44v3 in laryngeal premalignant and malignant lesions can be associated with tumorigenesis and invasion. Those strong positive expressions of CD44v3 may represent more aggressive pathology of the larynx. (Korean J Otolaryngol 2005;48:357-61)

참고문헌 (20)

  1. "and progressionto invasive squamous cell carcinoma of the upper aerodigestivetract. Am J Surg Patho 1989", pp.5~16
  2. "et al. Expression of CD44 variant proteins in human colorectalcancer is related to tumor progression. Cancer Res 1993", pp.4654~6
  3. "et al. Splice variants of CD44 in human cervical cancer stage IB toIIB. Gynecol Oncol 1995", pp.383~7 (1995)
  4. "Herrlich P. CD44 variant exon epitopes in primary breast cancer andlength of survival. Lancet 1995", pp.615~9 (1995), von Minckwitz G
  5. "et al. CD44 isoforms containing exon v3 are responsible for thepresentation of heparin binding growth factor. J Cell Biol 1995", pp.687~98 (1995)
  6. "Bourguignon LY. A new CD44v3-containingisoform is involved in tumor cell growth and migration duringhuman breast carcinoma progression. Front Biosci 1999", pp.1~8 (1999)
  7. "Whittle N.Proteoglycan forms of the lymphocyte homing receptor CD44 arealternatively spliced variants containing the v3 exon. J Cell Biol 1995", pp.673~85 (1995)
  8. "Seed B. CD44is the principal cell surface receptor for hyaluronate. Cell 1990", pp.1303~13
  9. "et al.Expression of CD 44 isoforms and β1 6-branched oligosaccharidesin human malignant melanoma is correlated with tumor progressionbut not with metastatic potential. J Cutan Pathol 1997", pp.206~11 (1997)
  10. "Franklin WA.Correlation of tumor markers p53 and Ki-67 with survival and metastasis in laryngeal squamous cellcarcinoma. Arch Otolaryngol Head Neck Surg 1996", pp.627~2 32 (1996)
  11. "et al. Expression of CD44 variant isoforms in malignant melanoma.Clin Cancer Res", pp.447~56 (1996)
  12. "etal. Expression of CD44 splice variants in squamous epithelia andsquamous cell carcinoma of the head and neck. J Pathol 1996", pp.66~73 (1996)
  13. "et al.A new variant of glycoprotein CD44 confers metastatic potential torat carcinoma cells. Cell 1991", pp.13~24
  14. "Hart IR. Isolation and characterization of humanmelanoma cell variants expressing high and low levels of CD44.Cancer Res 1991", pp.6660~7
  15. "Jalkanen S. Glycoprotein CD44expression and its association with survival in breast cancer. Am JPathol 1993", pp.867~74
  16. "Odell EW. Expression of CD44 variantexons by primary and metastatic oral squamous carcinomas. J OralPathol Med 1998", pp.303~7 (1998)
  17. "et al. CD44 standard and variant isoform expression in humanepidermal skin tumors is not correlated with tumor aggressiveness butdown-regulated during proliferation and tumor de-differentiation. IntJ Cancer 1996", pp.218~24 (1996)
  18. "Bourguignon LY.A novel CD44v3 isoform is involved in head and neck squamous cellcarcinoma. Otolaryngol Head Neck Surg 2001", pp.426~32 (2001)
  19. "CD44v6 expression in non small cell lung carcinoma.J Korean Pathol 2004", pp.93~9 (2004)
  20. "Chang JY. Differential expression of the humanmetastasis adhesion molecule CD44v in normal and carcinomatousstomach mucosa of chinese subjects. Caner 1995", pp.1065~71 (1995)

관련 논문AI추천

후두편평세포암종에서 Vascular Endothelial Growth Factor의 발현김훈, 이강원, 이규석, 임도형, 홍영호대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2003 · 제46권 제3호후두 편평상피암에서 β-catenin과 AdenomatousPolyposis Coli(APC) 단백의 발현박훈, 김동욱, 김효진, 박진규, 이병돈, 장혁순대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2005 · 제48권 제3호후두 및 하인두의 편평상피암종 발생에서 단일염기다형성의 임상적 의의김상윤, 김영란, 남순열, 박정제, 이시형, 최승호, 최은경대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2004 · 제47권 제9호비소세포폐암종에서 CD44s, CD44v5 및 CD44v6 발현의 임상병리학적 의의김재균, 송진미, 이경민, 이창훈대한병리학회 · Journal of Pathology and Translational Medicine2004 · 제38권 제2호후두에 발생한 방추세포암종 1예변재용, 안회영, 유영인, 홍석민대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2004 · 제47권 제4호위암에서 CD44s와 CD44v6 발현과 임상병리학적 상관관계에 관한 연구이주호, 임정화, 전호종대한병리학회 · Journal of Pathology and Translational Medicine2003 · 제37권 제5호

이 간행물의 다른 논문 (14건)

NF - ΚB 활성화와 면역학적 기능채성원pp. 284-288이신경외과 수술 후 이명의 변화김희남, 이원상, 김창우, 신유섭pp. 289-292중이 및 유양동 수술 후 발생한 지연성 안면신경 마비안병훈, 신승진, 박연호, 김동은, 이상윤, 김중강, 남성일, 최종원pp. 297-301겐타마이신으로 유발된 기니픽 전정유모세포 손상과 재생최원일, 정재윤, 이정구, 장선오, 전상준pp. 302-309구강암종 세포주에서 은행잎 추출물(EGb 761)의 세포고사 효과이광현, 윤주헌, 이주환, 권순호, 서형석, 김경수pp. 320-325
원문 보기